Education
About Us
Working with TipRanks
Follow Us
Ascletis Pharma, Inc. (HK:1672)
:1672
Earnings Data
Report Date
Mar 31, 2026TBA (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.35Last Year’s EPS
-0.19Same Quarter Last Year
Moderate Buy
Based on 2 Analysts Ratings
HK:1672 Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
HK:1672 Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Aug 15, 2025 | HK$15.60 | HK$17.74 | +13.72% |
Mar 26, 2025 | HK$8.70 | HK$8.38 | -3.68% |
Aug 30, 2024 | HK$0.83 | HK$0.85 | +2.41% |
Mar 25, 2024 | HK$1.59 | HK$1.52 | -4.40% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Ascletis Pharma, Inc. (HK:1672) report earnings?
Ascletis Pharma, Inc. (HK:1672) is schdueled to report earning on Mar 31, 2026, TBA (Confirmed).
What is Ascletis Pharma, Inc. (HK:1672) earnings time?
Ascletis Pharma, Inc. (HK:1672) earnings time is at Mar 31, 2026, TBA (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Ascletis Pharma, Inc. stock?
The P/E ratio of Ascletis Pharma, Inc. is N/A.
What is HK:1672 EPS forecast?
HK:1672 EPS forecast for the fiscal quarter 2025 (Q4) is -0.35.